Merus N.V. SEC Filings

Filed On	Filing
17 Feb 2026	SCHEDULE 13G/A
09 Jan 2026	15-12G
30 Dec 2025	Form 4: Genmab A/S, 10% owner Bought 2,978 shares ($289K) · Bought 1,052,806 shares ($102M) · Disposed of 75,867,199 shares (Open Market Purchase) ($7.36B)
30 Dec 2025	SCHEDULE 13D/A
30 Dec 2025	25-NSE/A
30 Dec 2025	SC 14D9/A
30 Dec 2025	SC TO-T/A
30 Dec 2025	8-K: Completion of Acquisition or Disposition of Assets; Notice of Delisting or Failure to Satisfy a Listing Rule +2 more
29 Dec 2025	Form 4: Genmab A/S, 10% owner Bought 15,710 shares ($1.52M) · Bought 561,042 shares ($54.4M) · Bought 96,082 shares ($9.32M) · 1 more
22 Dec 2025	Form 4: Genmab A/S, 10% owner Bought 212,177 shares ($20.6M) · Bought 66,264 shares ($6.43M)
19 Dec 2025	SCHEDULE 13D
18 Dec 2025	Form 4: Genmab A/S, 10% owner Bought 120,752 shares ($11.7M) · Bought 150,795 shares ($14.6M)
18 Dec 2025	Form 3: Genmab A/S, 10% owner Holds 71,463,077 shares of Common Shares, nominal value EUR 0.09 per share
12 Dec 2025	Form 4: Perry Gregory D, Chief Financial Officer & PFO Disposed of 662,126 Share Option (right to buy) (Disposition to Issuer)
12 Dec 2025	Form 4: Mehra Anand, Director Disposed of 103,939 Share Option (right to buy) (Disposition to Issuer)
12 Dec 2025	Form 4: Kanavy Len, Director Disposed of 98,124 Share Option (right to buy) (Disposition to Issuer)
12 Dec 2025	Form 4: Haddock Jason, Director Disposed of 30,881 Share Option (right to buy) (Disposition to Issuer)
12 Dec 2025	Form 4: Silverman Peter B., COO & GC Disposed of 505,914 Share Option (right to buy) (Disposition to Issuer)
12 Dec 2025	Form 4: Zohren Fabian, Chief Medical Officer Disposed of 233,943 Share Option (right to buy) (Disposition to Issuer)
12 Dec 2025	Form 4: Lundberg Sven Ante, Director Disposed of 83,435 shares (Tender Offer) ($8.09M) · Disposed of 1,999,248 Share Option (right to buy) (Disposition to Issuer)

Comments